Director/PDMR Shareholding

RNS Number : 5265U

GlaxoSmithKline PLC

22 December 2011

 



This announcement amends the original announcements released on 12 April 2011 at 18.00 (RNS No: 7966E); 12 July 2011 at 17.33 (RNS No: 2743K); and 11 October 2011 at 16.54 (RNS No: 9956P)

The Administrators of the GlaxoSmithKline Performance Share Plan (the "Plan") notified the Company and the under-mentioned persons on 21 December 2011 of an error in the market price of Ordinary shares which was used to calculate the notional number of shares received under the dividend reinvestment element of the Plan, in respect of dividends paid on 7 April 2011. The market price of Ordinary shares should have read 1216.50 pence rather than £12.22, and the participants' increased interests in Ordinary shares have been amended and the correct interests are set out below.

Given the cumulative nature of the dividend reinvestment, the correction in respect of the payment made on 7 April 2011 also had a minor impact on the calculation of the dividends reinvested for the affected Plan participants in respect of the dividend payments made on 7 July 2011 and 6 October 2011.

Amendments are identified with an asterisk (*).

Save as disclosed above, all other details remain unchanged. The full amended text is shown below.

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 12 April 2011 of an increase in their notional interests in Ordinary shares at a price of 1216.50 pence* per share and ADRs at a price of $39.96 per ADR following the notional re-investment of the dividend paid to shareholders on 7 April 2011.

	Ordinary shares	ADRs
Mr A P Witty	14,654.300*
Dr M M Slaoui		3,232.51
Mr S M Bicknell	1,100.996*
Mr J M Clarke	3,315.717*
Mrs D P Connelly		2,284.17
Mr M Dunoyer	1,585.952*
Mr E J Gray	2,387.414*
Mr S A Hussain	3,280.149*
Mr W C Louv		997.91
Dr D Pulman		1,589.94
Mr D S Redfern	1,331.022*
Mr J R Stéphenne	1,976.996*
Ms C Thomas	1,958.903*
Mr D E Troy		2,071.71
Dr P J T Vallance	1,219.257*
Mrs V A Whyte	101.106*

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rules 3.1.4R(1)(a).

V A Whyte

Company Secretary

12 April 2011

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 12 July 2011 of an increase in their notional interests in Ordinary shares at a price of 1366.50 pence per Ordinary share and ADRs at a price of $43.91 per ADR following the notional re-investment of the dividend paid to shareholders on 7 July 2011.

	Ordinary shares	ADRs
Mr A P Witty	16,127.194*
Dr M M Slaoui		4,323.445
Mr S M Bicknell	1,434.634*
Mr J M Clarke	4,015.431*
Mrs D P Connelly		2,544.286
Mr M Dunoyer	1,887.492*
Mr E J Gray	3,030.337*
Mr S A Hussain	3,962.111*
Mr W C Louv		1,304.354
Dr D Pulman		1,954.980
Mr D S Redfern	1,848.325*
Mr J R Stéphenne	2,322.380*
Ms C Thomas	2,664.317*
Mr P C Thomson	215.143*
Mr D E Troy		2,580.684
Dr P J T Vallance	2,618.026*
Ms E Walmsley	1,557.625*
Mrs V A Whyte	215.143*

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rules 3.1.4R(1)(a).

V A Whyte

Company Secretary

12 July 2011

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 11 October 2011 of an increase in their notional interests in Ordinary shares at a price of 1365 pence per Ordinary share and ADRs at a price of $42.37 per ADR following the notional re-investment of the dividend paid to shareholders on 6 October 2011.

	Ordinary shares	ADRs
Mr A P Witty	16,333.952*
Dr M M Slaoui		4,489.084
Mr S M Bicknell	1,453.027*
Mr J M Clarke	4,066.911*
Mrs D P Connelly		2,641.762
Mr M Dunoyer	1,911.691*
Mr E J Gray	3,069.188*
Mr S A Hussain	4,012.908*
Mr W C Louv		1,354.326
Dr D Pulman		2,029.879
Mr D S Redfern	1,872.021*
Mr J R Stéphenne	2,352.155*
Ms C Thomas	2,698.475*
Mr P C Thomson	217.901*
Mr D E Troy		2,679.555
Dr P J T Vallance	2,651.590*
Ms E Walmsley	1,577.595*
Mrs V A Whyte	217.901*

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

11 October 2011

 

END

 

 

RDSZLLFLFLFEFBD